Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Tango Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 138
- +18 vs. Q3 2024
- Shares held
- 106.4M
- +5.34M (+5.3%) vs. Q3 2024
- Total value
- $329.2M
- −$449.3M (−57.7%) vs. Q3 2024
- New holders
- 45
- 40 more added
- Sold out
- 27
- 28 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 247 | $6.60B |
| Q1 2026 | 194 | $3.78B |
| Q4 2025 | 170 | $1.53B |
| Q3 2025 | 141 | $1.18B |
| Q2 2025 | 115 | $651.7M |
| Q1 2025 | 122 | $147.0M |
| Q4 2024 | 138 | $329.2M |
| Q3 2024 | 121 | $781.2M |
| Q2 2024 | 120 | $846.0M |
| Q1 2024 | 126 | $781.2M |
| Q4 2023 | 121 | $927.1M |
| Q3 2023 | 100 | $999.9M |
| Q2 2023 | 89 | $226.8M |
| Q1 2023 | 92 | $275.9M |
| Q4 2022 | 82 | $498.4M |
| Q3 2022 | 87 | $246.8M |
| Q2 2022 | 77 | $319.1M |
| Q1 2022 | 72 | $528.2M |
| Q4 2021 | 58 | $741.0M |
| Q3 2021 | 46 | $844.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 249,646 | $771.4K | 0.00% | +249,646 | New |
| Bank of America Corp | 272,233 | $841.2K | 0.00% | +96,864+55.2% | Added |
| Walleye Capital LLC | 287,052 | $887.0K | 0.01% | +144,476+101.3% | Added |
| Morgan Stanley | 320,070 | $989.0K | 0.00% | −21,907−6.4% | Reduced |
| Susquehanna Fundamental Investments, LLC | 347,271 | $1.07M | 0.02% | +347,271 | New |
| Woodline Partners LP | 394,397 | $1.22M | 0.01% | +394,397 | New |
| UBS Group AG | 414,473 | $1.28M | 0.00% | −26,358−6.0% | Reduced |
| Superstring Capital Management LP | 474,955 | $1.47M | 1.29% | −124,093−20.7% | Reduced |
| Goldman Sachs Group Inc | 486,888 | $1.50M | 0.00% | −56,609−10.4% | Reduced |
| Acadian Asset Management LLC | 495,106 | $1.53M | 0.00% | +495,106 | New |
| Northern Trust Corp | 513,079 | $1.59M | 0.00% | +33,829+7.1% | Added |
| Charles Schwab Investment Management Inc | 513,429 | $1.59M | 0.00% | +26,192+5.4% | Added |
| Jacobs Levy Equity Management, Inc | 517,426 | $1.60M | 0.01% | +517,426 | New |
| OrbiMed Advisors LLC | 550,000 | $1.70M | 0.04% | +550,000 | New |
| Samsara BioCapital, LLC | 630,000 | $1.95M | 0.27% | 00.0% | Unchanged |
| Schroder Investment Management Group | 655,158 | $2.03M | 0.00% | +655,158 | New |
| Dimensional Fund Advisors LP | 662,776 | $2.05M | 0.00% | +302,087+83.8% | Added |
| ArrowMark Colorado Holdings LLC | 708,385 | $2.19M | 0.03% | 00.0% | Unchanged |
| Bessemer Group Inc | 708,384 | $2.19M | 0.00% | 00.0% | Unchanged |
| Casdin Capital, LLC | 1,188,349 | $3.67M | 0.25% | 00.0% | Unchanged |
| State Street Corp | 1,231,199 | $3.80M | 0.00% | −1,087,009−46.9% | Reduced |
| Geode Capital Management, LLC | 1,386,449 | $4.29M | 0.00% | +18,187+1.3% | Added |
| Citadel Advisors LLC | 1,626,759 | $5.03M | 0.00% | −1,067,366−39.6% | Reduced |
| Blue Owl Capital Holdings LP | 1,732,152 | $5.35M | 1.27% | +1,732,152 | New |
| Siren, L.L.C. | 2,603,897 | $8.05M | 0.36% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 2,712,008 | $8.38M | 0.99% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 2,804,410 | $8.67M | 0.61% | +2,804,410 | New |
| Balyasny Asset Management LLC | 3,279,196 | $10.1M | 0.02% | +592,000+22.0% | Added |
| T. Rowe Price Investment Management, Inc. | 3,345,551 | $10.3M | 0.01% | −1,677,595−33.4% | Reduced |
| Vanguard Group Inc | 3,985,225 | $12.3M | 0.00% | +339,922+9.3% | Added |
| Farallon Capital Management, L.L.C. | 4,000,000 | $12.4M | 0.07% | +4,000,000 | New |
| BlackRock, Inc. | 4,378,503 | $13.5M | 0.00% | +17,168+0.4% | Added |
| Gilead Sciences, Inc. | 4,854,443 | $15.0M | 0.97% | +4,854,443 | New |
| Nextech Invest AG | 5,533,980 | $17.1M | 2.77% | 00.0% | Unchanged |
| Boxer Capital Management, LLC | 10,380,999 | $32.1M | 2.73% | +10,380,999 | New |
| EcoR1 Capital, LLC | 10,630,736 | $32.8M | 1.32% | −2,700,000−20.3% | Reduced |
| TCG Crossover Management, LLC | 10,736,000 | $33.2M | 3.24% | +10,736,000 | New |
| TRV GP IV, LLC | 16,859,075 | $52.1M | 64.97% | 00.0% | Unchanged |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −8,198,642−100.0% | Sold out |
| Southpoint Capital Advisors LP | 0 | $0 | 0.00% | −5,000,000−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −2,294,206−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,540,000−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −750,000−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −384,500−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −343,152−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −131,508−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −102,955−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −79,978−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −73,122−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Braslyn Ltd. | 0 | $0 | 0.00% | −26,961−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −25,934−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −21,185−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −20,473−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −19,839−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −14,206−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −10,885−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −7,087−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −508−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −287−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Mass General Brigham, Inc | – | – | – | – | Not filed |